![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print January 16, 2003
Department of Biochemistry and Molecular Biology, Royal Free and University College Medical School, London NW3 2PF
Corresponding Author: n.beaumont{at}rfc.ucl.ac.uk
Ghrelin is a 28-residue peptide hormone that is principally released from the stomach during fasting and prior to eating. Two forms are present in human plasma; the unmodified peptide and a less abundant acylated version, in which octanoic acid is attached to the third residue, a serine, via an ester linkage. Only the acylated form of ghrelin acts as a ligand for the growth hormone secretagogue (GHS) receptor. It stimulates the release of growth hormone from the pituitary gland and initiates behavioural and metabolic adaptations to fasting. Here we show that an immobilized form of ghrelin specifically binds a species of high-density lipoprotein associated with the plasma esterase, paraoxonase, and clusterin. Both free ghrelin and paraoxon, a substrate for paraoxonase, can inhibit this interaction. Some endogenous ghrelin is found to co-purify with HDL during density gradient centrifugation. This interaction links the orexigenic peptide hormone ghrelin to lipid transport and a plasma enzyme that breaks down oxidised lipids in LDL. Furthermore, the interaction of the esterified hormone ghrelin with a species containing an esterase suggests a possible mechanism for the conversion of ghrelin to des-acyl ghrelin.
J. Biol. Chem, 10.1074/jbc.C200575200
Submitted on October 11, 2002
Revised on January 10, 2003
Accepted on January 16, 2003
Ghrelin can bind to a species of high-density lipoprotein associated with paraoxonase
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. V. Mayorov, N. Amara, J. Y. Chang, J. A. Moss, M. S. Hixon, D. I. Ruiz, M. M. Meijler, E. P. Zorrilla, and K. D. Janda Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice PNAS, November 11, 2008; 105(45): 17487 - 17492. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, G. A. Reynolds, A. Iranmanesh, and C. Y. Bowers Twenty-Four Hour Continuous Ghrelin Infusion Augments Physiologically Pulsatile, Nycthemeral, and Entropic (Feedback-Regulated) Modes of Growth Hormone Secretion J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3597 - 3603. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, C. E. Prudom, R. Nass, S. S. Pezzoli, M. C. Oliveri, M. L. Johnson, P. Veldhuis, D. A. Gordon, A. D. Howard, D. R. Witcher, et al. Novel Ghrelin Assays Provide Evidence for Independent Regulation of Ghrelin Acylation and Secretion in Healthy Young Men J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1980 - 1987. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Vestergaard, T. K. Hansen, L. C. Gormsen, P. Jakobsen, N. Moller, J. S. Christiansen, and J. O. L. Jorgensen Constant intravenous ghrelin infusion in healthy young men: clinical pharmacokinetics and metabolic effects Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1829 - E1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. De Vriese, M. Hacquebard, F. Gregoire, Y. Carpentier, and C. Delporte Ghrelin Interacts with Human Plasma Lipoproteins Endocrinology, May 1, 2007; 148(5): 2355 - 2362. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Choi, Y. M. Cho, M. K. Moon, H. H. Choi, H. D. Shin, H. C. Jang, S. Y. Kim, H. K. Lee, and K. S. Park Polymorphisms in the Ghrelin Gene Are Associated with Serum High-Density Lipoprotein Cholesterol Level and not with Type 2 Diabetes Mellitus in Koreans J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4657 - 4663. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Toshinai, H. Yamaguchi, Y. Sun, R. G. Smith, A. Yamanaka, T. Sakurai, Y. Date, M. S. Mondal, T. Shimbara, T. Kawagoe, et al. Des-Acyl Ghrelin Induces Food Intake by a Mechanism Independent of the Growth Hormone Secretagogue Receptor Endocrinology, May 1, 2006; 147(5): 2306 - 2314. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Gimenez-Palop, G. Gimenez-Perez, D. Mauricio, E. Berlanga, N. Potau, C. Vilardell, J. Arroyo, J.-M. Gonzalez-Clemente, and A. Caixas Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes Eur. J. Endocrinol., July 1, 2005; 153(1): 73 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kellokoski, S. M. Poykko, A. H. Karjalainen, O. Ukkola, J. Heikkinen, Y. A. Kesaniemi, and S. Horkko Estrogen Replacement Therapy Increases Plasma Ghrelin Levels J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2954 - 2963. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kojima and K. Kangawa Ghrelin: Structure and Function Physiol Rev, April 1, 2005; 85(2): 495 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Patterson, K. G. Murphy, C. W. le Roux, M. A. Ghatei, and S. R. Bloom Characterization of Ghrelin-Like Immunoreactivity in Human Plasma J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2205 - 2211. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. De Vriese, F. Gregoire, R. Lema-Kisoka, M. Waelbroeck, P. Robberecht, and C. Delporte Ghrelin Degradation by Serum and Tissue Homogenates: Identification of the Cleavage Sites Endocrinology, November 1, 2004; 145(11): 4997 - 5005. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. van der Lely, M. Tschop, M. L. Heiman, and E. Ghigo Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin Endocr. Rev., June 1, 2004; 25(3): 426 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. McLaughlin, F. Abbasi, C. Lamendola, R. S. Frayo, and D. E. Cummings Plasma Ghrelin Concentrations Are Decreased in Insulin-Resistant Obese Adults Relative to Equally Obese Insulin-Sensitive Controls J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1630 - 1635. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Marzullo, B. Verti, G. Savia, G. E. Walker, G. Guzzaloni, M. Tagliaferri, A. Di Blasio, and A. Liuzzi The Relationship between Active Ghrelin Levels and Human Obesity Involves Alterations in Resting Energy Expenditure J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 936 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Thompson, D. A. S. Gill, R. Davies, N. Loveridge, P. A. Houston, I. C. A. F. Robinson, and T. Wells Ghrelin and Des-Octanoyl Ghrelin Promote Adipogenesis Directly in Vivo by a Mechanism Independent of the Type 1a Growth Hormone Secretagogue Receptor Endocrinology, January 1, 2004; 145(1): 234 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Q. Purnell, D. S. Weigle, P. Breen, and D. E. Cummings Ghrelin Levels Correlate with Insulin Levels, Insulin Resistance, and High-Density Lipoprotein Cholesterol, But Not with Gender, Menopausal Status, or Cortisol Levels in Humans J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5747 - 5752. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |